Ipilimumab vs Mexiletine
Ipilimumab vs Mexiletine: Overview
This comparison examines the pharmacological differences between Ipilimumab and Mexiletine.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Ipilimumab β Antibody; Mexiletine β Small molecule.